Carbon dioxide is a major greenhouse gas that is responsible for global warming and renders harmful effects on the atmosphere. The unconstrained release of CO2 into the atmosphere should be prevented and various techniques have been developed in this regard to capture CO2 using different solvents and other compounds. Ionic liquids are a suitable candidate to capture CO2 due to their better solubility behaviour. In this work, two ionic liquids namely tetramethylammonium bromide (TMAB) and tetraethylammonium bromide (TEAB) are employed experimentally to capture CO2 and investigate their solubility behaviour. The study is performed at the temperature values of 303 K, 313 K, and 323 K and the pressure values of 5, 10, 15, and 20 bar equivalent to 0.5, 1.0, 1.5, and 2.0 MPa respectively. The concentrations of both ionic liquid solutions are 2.5 wt%, 5.0 wt%, and 10.0 wt%. The solubility results are considered in terms of mol fraction which is the ratio of moles of CO2 captured per moles of ionic liquid. The density and viscosity values are also determined for both compounds at respective conditions. COSMO-RS is used to generate the sigma profile, sigma surface, and Henry's constant of the ions involved in the study. CO2 is found to be soluble in both ionic liquids, but TEAB showed better solubility behaviour as compared to TMAB. The solubility of CO2 is found to be increasing with the increase in pressure while it decreases with the increase in temperature.
Chicken fat is a potential bioresource that can be developed into a commercial product. In this study, chicken fat, which is rich in unsaturated fatty acids, including oleic acid (C18:1) and linoleic acid (C18:2), was enzymatically interesterified with corn oil to produce a soft spread. Two interesterified products, sample 16 (4% enzyme, 4:1 mole ratio of chicken fat to corn oil, 50°C and 42 h of the interesterification process) and sample 17 (4% enzyme, 2:1 mole ratio of chicken fat to corn oil, 30°C and 42 h of the interesterification process), were selected based on the highest SFC at 30oC which were close to SFC values of commercial product. A morphological study showed that the final products had smaller and less dense fat particles, which explained the lower melting temperatures and solid fat content (3.2 and 3.5% for samples 16 and 17, respectively, at 20°C) compared to the commercial products (9.7, 6.8 and 7.7% for products A, B and C, respectively, at 20°C). However, both sample 16 and 17 had similar thermal properties to a vegetable-oil-based commercial product, with melting enthalpies (ΔH) of 58.45 J/g and 71.40 J/g, and were fully melted at 31.40°C and 35.41°C, respectively.
This study aimed to determine the effect of cooking on phytate content and the inhibitory effects of phytate on the bioavailability of minerals in eight Malaysian soy based dishes. Phytate was analyzed by using anion-exchange chromatography while minerals were analyzed by using Atomic Absorption Spectrophotometer. Molar ratios were obtained by dividing the mole of phytate to minerals. Phytate content was reduced in cooked dishes compared to the raw ones but it was not significantly different (P > 0.05). Raw, cooked and whole dish soy products contained 257.14-900.00, 182.14-803.57 and 289.29-910.71 mg/100 g phytate, respectively. Boiling and steaming have reduced most phytate content in the food samples. Molar ratios for phytate/minerals in these samples (phytate/Ca >0.17; phytate/Fe >1) indicated that phytate content inhibited the absorption of calcium and iron. However, the ratio for Ca × phytate/Zn in all samples was less than 200 which showed that phytate did not affect the bioavailability of zinc.
Choriocarcinoma is a malignant proliferation of syncytial trophoblast cells that do not form placental villi. It is a relatively rare and highly malignant variant of gestational trophoblastic disease. Although choriocarcinoma is mostly observed after a molar pregnancy, it may be preceded by any gestational event. It has been shown that even a partial mole can transform into choricarcinoma. Incidence rates of choriocarcinoma differ widely throughout the world. In Europe and North America, choriocarcinoma is reported to affect one in every 30,000 to 40,000 pregnancies, and one in 40 molar pregnancies. In South East Asia, choriocarcinoma is reported to affect one in every 500-3000 pregnancies. Following livebirth, choriocarcinoma with metastatic disease are important sequele (31%)(Tidy et al 1995). In the same study the reported median interval between antecedent pregnancy and choriocarcinoma is five months. Multi agent chemotherapy is required in the majority of patients (82%) for the high risk group. The prognosis for choriocarcinoma after a normal gestation is poorer. The mortality rate is also significantly higher than non-molar abortion (21%). Effective treatment with oral Methotrexate in metastatic choriocarcinoma to the lung confirmed the highly sensitive nature of this tumour to chemotherapy agent.